Comparative Pharmacology
Head-to-head clinical analysis: CLINIMIX 2 75 10 SULFITE FREE IN DEXTROSE 10 IN PLASTIC CONTAINER versus NOVAMINE 15.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLINIMIX 2 75 10 SULFITE FREE IN DEXTROSE 10 IN PLASTIC CONTAINER versus NOVAMINE 15.
CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER vs NOVAMINE 15%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Parenteral nutrition providing amino acids for protein synthesis and dextrose for caloric support, bypassing gastrointestinal tract.
Amino acids solution providing essential and non-essential amino acids for protein synthesis, tissue repair, and maintenance of nitrogen balance.
Intravenous administration of 2.75% amino acids and 10% dextrose at a rate to provide 1-2 g protein/kg/day and 5-25 g dextrose/kg/day based on metabolic needs. Infusion rate not to exceed 0.5 g dextrose/kg/hour initially.
Intravenous infusion. Adults: 1-2 g/kg/day of amino acids, adjusted based on metabolic needs, clinical status, and nitrogen balance. Typical infusion rate: 100-200 mL/hour of 15% solution (0.15-0.3 g/kg/hour).
None Documented
None Documented
Not applicable; components are endogenously regulated (amino acids: minutes to hours; dextrose: ~1-2 hours). For continuous infusion, steady-state achieved within 4-6 hours.
Variable; amino acid half-lives range from minutes to hours depending on individual amino acid. Clinical context: continuous infusion achieves steady state within 24 hours in normal renal function.
Renal: ~50% as unchanged amino acids and dextrose metabolites within 6 hours; remainder metabolized to CO2 and H2O, eliminated via lungs and urine.
Amino acids are metabolized; nitrogen is excreted primarily as urea in urine (80% of nitrogen), with minimal fecal elimination (<5%).
Category C
Category C
Parenteral Nutrition
Parenteral Nutrition